A 42-year-old woman presents with a swollen, painful, erythematous left breast which does not respond to a 10-day course of oxacillin. Ultrasound reveals no abscess. The next step in management should be:
**Core Concept**
The patient's presentation suggests a breast infection that is resistant to conventional antibiotic therapy, likely due to the presence of methicillin-resistant Staphylococcus aureus (MRSA) or another resistant organism. This requires a change in treatment approach to cover the resistant pathogen.
**Why the Correct Answer is Right**
The patient's lack of response to oxacillin, a beta-lactam antibiotic, suggests that the causative organism is resistant to this class of antibiotics. MRSA is a well-known cause of skin and soft tissue infections, including breast infections, and is resistant to many beta-lactam antibiotics. The next step in management would be to switch to an antibiotic that is effective against MRSA, such as vancomycin or clindamycin.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not address the underlying issue of antibiotic resistance. Simply continuing the same antibiotic therapy is unlikely to be effective.
**Option B:** This option is incorrect because there is no indication that the patient has a fungal infection, and antifungal therapy would not be effective against a bacterial infection.
**Option C:** This option is incorrect because there is no indication that the patient has a viral infection, and antiviral therapy would not be effective against a bacterial infection.
**Clinical Pearl / High-Yield Fact**
When treating skin and soft tissue infections, it is essential to consider the possibility of antibiotic resistance, particularly MRSA, and to switch to an effective antibiotic if the patient does not respond to initial therapy.
**Correct Answer:** C. Clindamycin